The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Marketwire

BioExx Provides Update on Strategic Partner Process

Tuesday, April 30, 2013

BioExx Provides Update on Strategic Partner Process

08:00 EDT Tuesday, April 30, 2013

TORONTO, ONTARIO--(Marketwired - April 30, 2013) - BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:BXI), today announced that it has signed a Letter of Intent with its proposed rapeseed (canola) processing partner ("Business Partner") with regards to the formation of a joint venture for the commercial scale deployment of the Company's canola protein production technology. Both companies remain committed to the completion of the transaction.

Following further discussions surrounding the terms of the proposed joint venture, the previous Financial Partner candidate was unable to commit to mutually acceptable terms and discussions have been terminated for the time being. BioExx and the Business Partner will continue to work together to identify and secure an appropriate financial partner for the proposed project.

Within the current joint venture discussions, BioExx would provide its proprietary protein technology and expertise and the Business Partner would contribute its proprietary oil processing technology and expertise. The Letter of Intent commits the two companies to find an alternate financial partner to supply equity capital for the construction and commissioning of the new facility. The Company will provide further updates on the progress of the proposed joint venture as additional details become available.

Independent of the proposed joint venture, BioExx has also been approached by an integrated and diversified global agri-business company for a potential strategic corporate relationship based on BioExx's proprietary food-grade protein technology. These discussions are in preliminary stages but are moving forward positively and are oriented towards a long-term relationship with global scope.

"The compatibility of our food-grade protein technology with our Business Partner's specialty edible oil technology remains intact. Both parties remain committed to a joint venture that combines these complementary technologies to extract full value from the growing opportunity that exists for high value protein and speciality oil," said Chris Schnarr, CEO of BioExx. "However, we must also ensure that a single project opportunity does not compromise our most valuable asset, which is our intellectual property, in order to preserve this in the interest of the current and much larger strategic opportunity."

The previously announced sale of various physical assets of the Company's wholly-owned subsidiary, BioExx Proteins of Saskatoon Inc., is progressing well, with several interested buyers. The Company is confident it will be able to maximize the value of the assets to address its financial obligations and provide additional working capital. BioExx and its secured lender are committed to co-operation on the timing and application of proceeds from the eventual sale of the various physical assets.

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com.

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. Furthermore, there can be no guarantees that any agreement will be signed with a strategic partner. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.

FOR FURTHER INFORMATION PLEASE CONTACT:

Contact Information:
BioExx Specialty Proteins Ltd.
Chris Schnarr
Chief Executive Officer
(416) 588-4442 x111
cschnarr@bioexx.com
www.bioexx.com


TMX Equicom
Ross Marshall
Investor Relations
(416) 815-0700 x238
rmarshall@tmxequicom.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections